HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Steven F. Bolling Mark A. Groh Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bolling, S. F. Articles by Gallagher, K. P. Search for Related Content PubMed PubMed Citation Articles by Bolling, S. F. Articles by Gallagher, K. P.

Ann Thorac Surg 1992;54:93-98
© 1992 The Society of Thoracic Surgeons

---

Articles

Acadesine (AICA-riboside) improves postischemic cardiac recovery

Thoracic Surgery Research Laboratory, Departments of Surgery (Thoracic Surgery) and Physiology, University of Michigan, Ann Arbor, Michigan USA

Accepted for publication December 17, 1991.

^_* Address reprint requests to Dr Bolling, Section of Thoracic Surgery, The University of Michigan Hospitals, 1500 E Medical Center Dr, 2120 Taubman Center, Box 0344, Ann Arbor, MI 48109.

To test if acadesine (5-aminoimidazole-4-carboxamide riboside), a purine precursor, has cardioprotective effects, 16 dogs were placed on total cardiopulmonary bypass and subjected to global myocardial ischemia. Hemodynamic recovery was compared between a control (n = 8) group receiving standard cardioplegia and an acadesine (n = 8) group pretreated with intravenous acadesine (2.5 mg · kg^–1 · min^–1 for 5 minutes, then 0.5 mg · kg^–1 · min^–1) before ischemia, during ischemia, and until 10 minutes after removal of the aortic crossclamp. Additionally, in the acadesine group the cardioplegia also contained 20 µmol/L acadesine. While the dogs were on cardiopulmonary bypass, global warm myocardial ischemia was induced by aortic cross-clamping for 5 minutes under normothermic conditions to simulate an angioplasty accident. Five minutes after aortic crossclamping, hypothermic cardioplegia (30 mL/kg) was administered. The left anterior descending coronary artery was occluded before the first infusion of cardioplegia to simulate poor cardioplegia delivery that can occur during an emergency coronary artery bypass procedure after an angioplasty accident. The left anterior descending artery occlusion was released, and additional cardioplegia (15 mL/kg) infusions were made every 30 minutes thereafter during 120 minutes of cardioplegic ischemia. Thirty minutes after reperfusion, all animals in both groups were weaned from bypass and recovery data were obtained to compare with baseline preischemic values. There were no significant differences in heart rate, left atrial pressure, or systemic vascular resistance between groups after weaning from bypass. Peak developed pressure recovered to 79% ± 19% (mean ± standard deviation) of baseline in the acadesine group compared with 56% ± 22% in the control group (p < 0.05). Additionally, recovery of mean arterial blood pressure (acadesine versus control: 71% ± 15% versus 45% ± 21%; p < 0.03), positive first derivative of left ventricular pressure (71% ± 16% versus 35% ± 13%; p < 0.01), and cardiac output (109% ± 26% versus 53% ± 39%; p < 0.01) were also significantly better with acadesine. Mixed venous oxygen saturation (preischemic baseline for both groups = 93%) was significantly lower in the control group (54% ± 19%) compared with the acadesine group (90% ± 8%) after bypass, a difference in extraction suggesting that oxygen delivery was better when acadasine was used. We conclude that acadesine is a promising cardioprotective agent for use during global ischemia.

This article has been cited by other articles:

				T. O. Cheng, A. Jovanovic, J. R. Lopez, A. E. Alekseev, W. K. Shen, and A. Terzic Adenosine and K+-Induced Ca2+ Loading Ann. Thorac. Surg., August 1, 1997; 64(2): 588 - 589. [Full Text]

				P. Menasche, W. R. E. Jamieson, W. Flameng, M. K. Davies, and on behalf of the Multinational Acadesine Study Gro ACADESINE: A NEW DRUG THAT MAY IMPROVE MYOCARDIAL PROTECTION IN CORONARY ARTERY BYPASS GRAFTINGResults of the first international multicenter study J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 1096 - 1106. [Abstract] [Full Text]

				E. R. Rosenkranz Substrate enhancement of cardioplegic solution: Experimental studies and clinical evaluation Ann. Thorac. Surg., September 1, 1995; 60(3): 797 - 800. [Abstract] [PDF]

				W. D. Dietrich, L. P. Miller, R. Prado, S. Dewanjee, N. Alexis, M. K. Dewanjee, and H. Gruber Acadesine Reduces Indium-Labeled Platelet Deposition After Photothrombosis of the Common Carotid Artery in Rats Stroke, January 1, 1995; 26(1): 111 - 116. [Abstract] [Full Text]

				D. A. Hudspeth, M. W. Williams, Z.-Q. Zhao, H. Sato, K. Nakanishi, D. S. McGee, J. W. Hammon Jr, J. Vinten-Johansen, and D. G. L. Van Wylen Pentostatin-augmented interstitial adenosine prevents postcardioplegia injury in damaged hearts Ann. Thorac. Surg., September 1, 1994; 58(3): 719 - 727. [Abstract] [PDF]

				F. W. Sellke, M. Friedman, S. Y. Wang, R. N. Piana, H. B. Dai, and R. G. Johnson Adenosine and AICA-riboside fail to enhance microvascular endothelial preservation Ann. Thorac. Surg., July 1, 1994; 58(1): 200 - 206. [Abstract] [PDF]